中药注射剂联合同步放化疗治疗鼻咽癌的多维贝叶斯网络Meta分析
该网络Meta分析纳入37项RCT共2581例鼻咽癌患者,比较不同中药注射剂联合同步放化疗的疗效与安全性。结果显示榄香烯注射液联合方案临床有效率最高,康艾注射液在改善体能状态及减少不良反应方面综合表现较好。
要点
- 榄香烯注射液联合同步放化疗的临床有效率概率最高(78.07%)。
- 康艾注射液联合方案在白细胞减少和血小板减少排名最优。
- 参芪扶正、消癌平、参麦注射液分别改善体能状态、恶心呕吐和≥3级口腔黏膜炎最优。
核心结论
- 当前临床证据表明榄香烯注射液联合同步放化疗的临床有效率最佳,康艾注射液可能在改善体能状态和减少不良反应方面具有综合较好影响。
主要发现
- 与单纯同步放化疗相比,榄香烯注射液和复方苦参注射液联合方案与临床有效率显著改善相关。
- 榄香烯注射液联合同步放化疗的临床有效率概率为78.07%,在干预中最高。
- 参芪扶正注射液、消癌平注射液和参麦注射液联合同步放化疗分别在体能状态(79.02%)、恶心呕吐(86.35%)和≥3级口腔黏膜炎(78.14%)排名最优。
- 康艾注射液联合同步放化疗在白细胞减少(90.80%)和血小板减少(91.04%)排名最优,且在改善体能状态及减少白细胞减少、血小板减少、≥3级口腔黏膜炎和恶心呕吐的多维聚类分析中表现更好。
关键数值与推荐
- 评估指标包括临床有效率、体能状态、≥3级口腔黏膜炎、恶心呕吐、白细胞减少和血小板减少。
临床怎么用
- 临床可结合患者主要问题参考概率排名选择中药注射剂联合同步放化疗方案,如追求临床有效率可考虑榄香烯注射液,关注综合不良反应管理可考虑康艾注射液。
局限性
- 由于该网络Meta分析的局限性,需要更多多中心、高质量、头对头随机对照试验来充分支持本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction: Given the wide utilization of Chinese herbal injections in the treatment of nasopharyngeal carcinoma (NPC), this network meta-analysis (NMA) was devised to compare the clinical efficacy and safety of different Chinese herbal injections combined with concurrent chemoradiotherapy (CCRT) against NPC. Methods: Randomized controlled trials (RCTs) were retrieved from seven electronic databases from the date of database establishment to October 5, 2020. Study selection and data extraction conformed to a priori criteria. Focusing on clinical effective rate, performance status, grade ≥3 oral mucositis, nausea and vomiting, leukopenia, and thrombopenia, this NMA was performed with Review Manager 5.3.5, Stata 13.1, WinBUGS 1.4.3, and R 4.0.3 software. Results: Ten inventions from 37 RCTs involving 2,581 participants with NPC that evaluated the clinical effective rate, nausea and vomiting, leukopenia, thrombopenia, and grade ≥3 oral mucositis were included. Compared with CCRT alone, Elemene injection and Compound Kushen injection were associated with significantly improved clinical effective rates, and Elemene injection plus CCRT had the highest probability in terms of clinical effective rate (78.07%) compared with the other interventions. Shenqifuzheng injection, Xiaoaiping injection, and Shenmai injection ranked the best in terms of performance status (79.02%), nausea and vomiting (86.35%), and grade ≥3 oral mucositis (78.14%) when combined with CCRT. Kangai injection combined with CCRT ranked ahead of the other injections in terms of leukopenia (90.80%) and thrombopenia (91.04%), and had a better impact on improving performance status and reducing leukopenia, thrombopenia, grade ≥3 oral mucositis, and nausea and vomiting in the multidimensional cluster analysis. Conclusion: Current clinical evidence indicates that Elemene injection combined with CCRT has the best clinical effective rate and that Kangai injection might have a comprehensively better impact on improving performance status and reducing adverse reactions against NPC. Additionally, due to the limitations of this NMA, more multicenter, high-quality, and head-to-head RCTs are needed to properly support our findings.
引用
- Wu Z, Wang H, Wu J, et al. Investigation on the Efficiency of Chinese Herbal Injections combined with Concurrent Chemoradiotherapy for Treating Nasopharyngeal Carcinoma based on Multidimensional Bayesian Network Meta-analysis. Front Pharmacol. 2021. PMID: 34177576. doi:10.3389/fphar.2021.656724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。